You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The Cutting Edge Vorinostat for the Treatment of Bullous Pemphigoid in the Setting of Advanced, Refractory Cutaneous T-Cell Lymphoma
Jennifer M. Gardner; Katherine G. Evans; Steven Goldstein; Ellen J. Kim; Carmela C. Vittorio; Alain H. Rook
Arch Dermatol 2009; 145: 985-988.
[Extract][Full text][PDF]
Observations Interaction of Topical Sulfacetamide and Topical Dapsone With Benzoyl Peroxide
Observations Cytomegalovirus Disease During Severe Drug Eruptions: Report of 2 Cases and Retrospective Study of 18 Patients With Drug-Induced Hypersensitivity Syndrome
Evidence-Based Dermatology: Research Commentaries The Misperception That Clinical Trial Data Reflect Long-term Drug Safety: Lessons Learned From Efalizumab's Withdrawal
Tamar Nijsten; Phyllis I. Spuls; Luigi Naldi; Robert S. Stern
Arch Dermatol 2009; 145: 1037-1039.
[Extract][Full text][PDF]
Research Letters Scalp Dermatomyositis Revisited
Jeremy S. Tilstra; Noel Prevost; Pooja Khera; Joseph C. English III
Arch Dermatol 2009; 145: 1062-1063.
[Extract][Full text][PDF]
Correspondence Tretinoin: An Established Long-term Safety Profile
William Powers Jr; Stanley S. Shapiro; Annie Heremans
Arch Dermatol 2009; 145: 1063-1064.
[Extract][Full text][PDF]
Correspondence Tretinoin: An Established Long-term Safety Profile—Reply
